last data update: 2011/10/20, 07:12

Website loading time

during the test: 3.84 s

cable connection (average): 3.99 s

DSL connection (average): 4.13 s

modem (average): 11.85 s

HTTP headers

Information about DNS servers

pharmaasia.comA120.136.46.142IN43200
pharmaasia.comSOAns.rackspace.com.pharmaasia.comhostmaster.rackspace.com.pharmaasia.com12691517973600 300 1814400 300 IN 300
pharmaasia.comNSns2.rackspace.comIN43200
pharmaasia.comNSns.rackspace.comIN43200

Received from the first DNS server

Request to the server "pharmaasia.com"
You used the following DNS server:
DNS Name: ns2.rackspace.com
DNS Server Address: 65.61.188.4#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 30792
flag: qr aa rd REQUEST: 1, ANSWER: 4, AUTHORITY: 0, ADDITIONAL: 0

REQUEST SECTION:
pharmaasia.com. IN ANY

ANSWER SECTION:
pharmaasia.com. 300 IN SOA ns.rackspace.com.pharmaasia.com. hostmaster.rackspace.com.pharmaasia.com. 1269151797 3600 300 1814400 300
pharmaasia.com. 86400 IN NS ns.rackspace.com.
pharmaasia.com. 86400 IN NS ns2.rackspace.com.
pharmaasia.com. 86400 IN A 120.136.46.142

Received 157 bytes from address 65.61.188.4#53 in 14 ms

Received from the second DNS server

Request to the server "pharmaasia.com"
You used the following DNS server:
DNS Name: ns.rackspace.com
DNS Server Address: 69.20.95.4#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 37978
flag: qr aa rd REQUEST: 1, ANSWER: 4, AUTHORITY: 0, ADDITIONAL: 0

REQUEST SECTION:
pharmaasia.com. IN ANY

ANSWER SECTION:
pharmaasia.com. 300 IN SOA ns.rackspace.com.pharmaasia.com. hostmaster.rackspace.com.pharmaasia.com. 1269151797 3600 300 1814400 300
pharmaasia.com. 86400 IN NS ns.rackspace.com.
pharmaasia.com. 86400 IN NS ns2.rackspace.com.
pharmaasia.com. 86400 IN A 120.136.46.142

Received 157 bytes from address 69.20.95.4#53 in 14 ms

Subdomains (the first 50)

Typos (misspells)

oharmaasia.com
lharmaasia.com
-harmaasia.com
0harmaasia.com
pgarmaasia.com
pbarmaasia.com
pnarmaasia.com
pjarmaasia.com
puarmaasia.com
pyarmaasia.com
phzrmaasia.com
phsrmaasia.com
phwrmaasia.com
phqrmaasia.com
phaemaasia.com
phadmaasia.com
phafmaasia.com
phatmaasia.com
pha5maasia.com
pha4maasia.com
pharnaasia.com
pharkaasia.com
pharjaasia.com
pharmzasia.com
pharmsasia.com
pharmwasia.com
pharmqasia.com
pharmazsia.com
pharmassia.com
pharmawsia.com
pharmaqsia.com
pharmaaaia.com
pharmaazia.com
pharmaaxia.com
pharmaadia.com
pharmaaeia.com
pharmaawia.com
pharmaasua.com
pharmaasja.com
pharmaaska.com
pharmaasoa.com
pharmaas9a.com
pharmaas8a.com
pharmaasiz.com
pharmaasis.com
pharmaasiw.com
pharmaasiq.com
harmaasia.com
parmaasia.com
phrmaasia.com
phamaasia.com
pharaasia.com
pharmasia.com
pharmasia.com
pharmaaia.com
pharmaasa.com
pharmaasi.com
hparmaasia.com
pahrmaasia.com
phramaasia.com
phamraasia.com
pharamasia.com
pharmaasia.com
pharmasaia.com
pharmaaisa.com
pharmaasai.com
ppharmaasia.com
phharmaasia.com
phaarmaasia.com
pharrmaasia.com
pharmmaasia.com
pharmaaasia.com
pharmaaasia.com
pharmaassia.com
pharmaasiia.com
pharmaasiaa.com

Location

IP: 120.136.46.142

continent: AS, country: Hong Kong (HKG), city:

Website value

rank in the traffic statistics:

There is not enough data to estimate website value.

Basic information

website build using CSS

code weight: 56.08 KB

text per all code ratio: 46 %

title: Drug Manufacturing, Drug Delivery, Clinical Trials News | PharmaAsia

description:

keywords:

encoding: utf-8

language: en

Website code analysis

one word phrases repeated minimum three times

PhraseQuantity
Oct11
in10
and6
appoints6
of6
for5
to4
Emerging3
AMRI3
Markets3
as3
BeiGene3
acquire3
the3
affairs3
medical3
News3
Takeda3
research3
123
President3
173
boost3
Pharmaceutical3

two word phrases repeated minimum three times

PhraseQuantity
to acquire3
medical affairs3
12 Oct3
17 Oct3
Emerging Markets3

three word phrases repeated minimum three times

B tags

U tags

I tags

images

file namealternative text
Pharmaceutical and biotech companies boost resources in medical affairs affiliates
Roche signs definitive agreement to acquire Anadys Pharmaceuticals
Takeda appoints Jostein Davidsen Head of Emerging Markets
ICON appoints Colin Stanley President of DOCS
BeiGene in-licenses two clinical-stage oncology compounds
AMRI appoints new President, India Operations
September-October 2011
Special Report
Dr Reddy
House Ad
Logo
Ten Alps Asia

headers

H1

H2

Pharmaceutical and biotech companies boost resources in medical affairs affiliates

Roche signs definitive agreement to acquire Anadys Pharmaceuticals

Takeda appoints Jostein Davidsen Head of Emerging Markets

ICON appoints Colin Stanley President of DOCS

BeiGene in-licenses two clinical-stage oncology compounds

AMRI appoints new President, India Operations

Latest News

On PharmaAsia

Popular Tags

Follow us on PharmaAsia

Current IssueSeptember-October 2011

Special Report

Whitepapers / Press Releases

Editor's Choice

Trending Topics

ICON

international liver cancer congress

BioAlliance

AllCells

Biogen

Quintiles

A*STAR

Agilent

Internet Explorer 6 Detected Close

H3

Pharmaceutical and biotech companies boost resources in medical affairs affiliates

Roche signs definitive agreement to acquire Anadys Pharmaceuticals

Takeda appoints Jostein Davidsen Head of Emerging Markets

ICON appoints Colin Stanley President of DOCS

BeiGene in-licenses two clinical-stage oncology compounds

AMRI appoints new President, India Operations

Latest News

On PharmaAsia

Popular Tags

Follow us on PharmaAsia

Current IssueSeptember-October 2011

Special Report

Whitepapers / Press Releases

Editor's Choice

Trending Topics

ICON

international liver cancer congress

BioAlliance

AllCells

Biogen

Quintiles

A*STAR

Agilent

Internet Explorer 6 Detected Close

H4

Something interesting to share?

Ten Alps Communications Asia Interactive Network

H5

H6

internal links

addressanchor text
Pharmaceutical and biotech companies boost resources in medical affairs affiliates
Roche signs definitive agreement to acquire Anadys Pharmaceuticals
Takeda appoints Jostein Davidsen Head of Emerging Markets
ICON appoints Colin Stanley President of DOCS
BeiGene in-licenses two clinical-stage oncology compounds
AMRI appoints new President, India Operations
Pharmaceutical and biotech companies boost resources in medical affairs affiliates
ICON appoints Colin Stanley President of DOCS
Takeda appoints Jostein Davidsen Head of Emerging Markets
Roche signs definitive agreement to acquire Anadys Pharmaceuticals
BeiGene in-licenses two clinical-stage oncology compounds
AMRI appoints new President, India Operations
Nuvilex’s affiliate presents Cell in a Box technology in Seoul
Progenra and Ono Pharmaceutical enter into research collaboration
Agilent Technologies supports research at the Broad Institute
Launch of BioLynx provides a boost for the international malaria research community
Bristol-Myers Squibb Foundation announces collaboration with WHO’s Stop TB Department
More News
Most Read
Press Releases
Whitepapers
Pharma Logistics Supplement: Asian Potential
Agilent Technologies and Chungnam National University collaborate to further glycomics research
Bristol-Myers Squibb completes acquisition of Amira Pharmaceuticals
Puracyp and Promega combine cell lines and assay systems
Dr Reddy's starts phase 2 study with CETP inhibitor in dyslipidemia patients
ICON selected as provider for early phase clinical development by BMS
GE Healthcare to invest US$1 billion in new oncology solutions
Boehringer Ingelheim licenses ProBioGen's GlymaxX technology
More Most Viewed
Pharmaceutical and biotech companies boost resources in medical affairs affiliates
Roche signs definitive agreement to acquire Anadys Pharmaceuticals
Takeda appoints Jostein Davidsen Head of Emerging Markets
ICON appoints Colin Stanley President of DOCS
BeiGene in-licenses two clinical-stage oncology compounds
AMRI appoints new President, India Operations
Submit Your Press Release To Us
Submit Your Whitepaper To Us
ICON
international liver cancer congress
BioAlliance
AllCells
Biogen
Quintiles
A*STAR
Agilent
Abbott
Promega
Puracyp
Drug Discovery
Download eBook
From cancer research to innovative applications: The Dutch revolution
Strength to strength
API China, Interphex China Autumn 2010: Bringing the world closer
Send it to us!
Editor's Choice
Dr Reddy
Dr Reddy's starts phase 2 study with CETP inhibitor in dyslipidemia patients
AllCells expands operations in Shanghai, China
Abbott receives FDA approval for ALK gene test for lung cancer therapy selection
Paromomycin added to national essential medicines list by government of Nepal
Pharmacovigilance: At the intersection of healthcare and life sciences
Vasolan Receives Approval for Atrial Fibrillation/Flutter and Paroxysmal Supraventricular Tachycardia
ICON
ICON appoints Colin Stanley President of DOCS
ICON selected as provider for early phase clinical development by BMS
ICON appoints President of Early Phase Division
ICON announces Asia Pacific seminar series
ICON, Pfizer announce strategic partnership for clinical R&D
international liver cancer congress
BioAlliance Pharma presents orphan drug survival results at international liver cancer congress
BioAlliance
BioAlliance Pharma presents orphan drug survival results at international liver cancer congress
BioAlliance Pharma complements its portfolio with a European licence for ondansetron RapidFilm
BioAlliance acquires European Rights for Ondansetron Oral Spray
AllCells
AllCells expands operations in Shanghai, China
Biogen
Boehringer Ingelheim licenses ProBioGen's GlymaxX technology
Biogen Idec, Abbott report positive results from trial of daclizumab HYP
Biogen Idec identify novel approach for treatment of multiple sclerosis
Biogen Idec identify novel approach for treatment of multiple sclerosis
Biogen Idec celebrates World MS Day
Quintiles
Quintiles find innovation is vital to future of biopharma
KoNECT, Quintiles partner to advance clinical research education
Quintiles opens global service operations center in India
Quintiles in partnership with University of Malaya
Quintiles Launches Tissue Testing Services In China
A*STAR
A*STAR SIMTech launches microfluidics foundry
Agilent and A*STAR launch drug screening platform in Singapore
Agilent and A*STAR launch drug screening platform in Singapore
A*Star scientists make breakthroughs against cancer
Detecting DNA the Electrochemical Way
Agilent
Agilent Technologies supports research at the Broad Institute
Agilent Technologies’ LC/MS manufacturing achieves ISO 13485 certification
Agilent Technologies and Chungnam National University collaborate to further glycomics research
Agilent and A*STAR launch drug screening platform in Singapore
Agilent and A*STAR launch drug screening platform in Singapore
Logo
Hot Topics
air to china
australia freight
china forwarders
Home
Latest News
Categories
Drug Discovery
Drug Development
Drug Manufacturing
Drug Delivery
Clinical Trials
Alliances and Mergers
QA/QC and Compliance
Pharmaceutical Processing and Packaging
Event Calendar
more
Magazine Archives
RSS Feeds
About Pharma Asia
Contact Us
Media Kit
Drug Manufacturing, Drug Delivery, Clinical Trials
Terms and Conditions of Use
Privacy Policy
Sign In
Register
About Us
Bookmark This Page
Skip, no thanks

external links

addressanchor text
img
img
img
img
img
img
img
img
img
img
img
img
img
img
House Ad
Subscription
Food Processing, Food Packaging, Ingredients
Control Systems, Process Instruments, Motors and Drives
PCB Production, Microelectronics Components, Surface Mounting
Electronics Manufacturing China
Logistics Management, Supply Chain, Warehouse Management
Air Cargo Carriers and Terminals, Freight Forwarders, Airports
Broadcasting, Post-Production, Digital Animation
IPTV, Cable TV, TV Advertising
Asian Television Awards
OnScreenAsia
Tourism, Hotels, Aviation, Travel Agents, MICE
TravelWeekly China
Ten Alps Communications Asia.
About Ten Alps Asia
Our Publications
Our Locations